CANVAXIN

Swiss trademark · 497789 · Word mark · Deleted

Register entry

Registration number
497789
Application number
12020/2001
Status
Deleted
Type
Word mark
Filed
Dec 20, 2001
Registered
Apr 16, 2002
Published
Apr 30, 2002
Deleted
Jul 23, 2012
Reason
Not renewed
Priority
22.06.2001 US
Remarks
Teilpriorität, Details im Aktenheft.
Source
Swissreg

Goods and services

Pharmaceuticals

Produits pharmaceutiques, y compris produits pharmaceutiques destinés au traitement du cancer.

Science, technology and IT

Recherche médicale et scientifique pour les tiers, notamment recherche et développement de vaccins pour le cancer.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 23, 2012

    Deleted, not renewed

    Published in Swissreg on 23.07.2012

  2. Feb 2, 2011

    Agent’s address changed

    Representative
    Bovard SA, Ingénieurs-conseils, Optingenstrasse 16, 3000 Berne 25 → BOVARD SA, Conseils en propriété intellectuelle, Optingenstrasse 16, 3000 Berne 25

    Published in Swissreg on 02.02.2011

  3. Apr 30, 2002

    Registered

    Published in the SOGC no. 82 of 30.04.2002

Parties

Holder

CancerVax Corporation

5931 Darwin Court, Carlsbad (CA 92008-7302), US

Agent

Bovard AG

BOVARD SA

Conseils en propriété intellectuelle Optingenstrasse 16, 3000 Berne 25

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.